Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

Table of Contents

(10)
The option vested over four years of service following March 15, 2008, with 25% vesting upon completion of one year of service and in 36 equal monthly installments thereafter.

(11)
The option vested in equal monthly installments over 12 months of service following March 15, 2009.

(12)
The option vested in equal monthly installments over 12 months of service following March 15, 2010.

(13)
Five percent of the option vests upon the achievement of up to three of four corporate milestones, with an additional 15% of the option vesting in substantially equal monthly installments over 11 months of service following each such milestone. Such milestones must be achieved, if ever, prior to the ninth anniversary of the date of grant of the option. No more than 60% of the option, in the aggregate, may vest based on the achievement of milestones. In addition, following the earliest of our deemed liquidation, the completion of this offering, or the consummation of a strategic transaction (including without limitation the exclusive license of a material asset of the company, a spin-off and subsequent sale of one of our business units), 10% of the option will vest on the first day of the month following such event, with an additional 30% of the option vesting in substantially equal monthly installments over 11 months of service following such event.

(14)
The RSUs vest on the earlier to occur of this offering or our change in control, provided the grantee remains in continuous service through such date or is terminated by us other than for cause within three months prior to such date. The 9,000,000 shares of common stock issuable under this RSU award will not be adjusted as a result of this offering.

(15)
The option vested over four years of service following February 25, 2008, with 25% vesting upon completion of one year of service and in 36 equal monthly installments thereafter.

(16)
The option vested over four years of service following January 24, 2006, with 25% vesting upon completion of one year of service and in 36 equal monthly installments thereafter.

(17)
The option vested 65% after the achievement of certain performance goals and then in substantially equal monthly installments over 18 months thereafter. The performance goals were achieved on January 23, 2013.

(18)
The option vested in equal monthly installments over 12 months following March 15, 2008.

(19)
The option vested over four years of service following September 24, 2008, with 25% vesting upon completion of one year of service and in 36 equal monthly installments thereafter.

        In addition, in the event that we are subject to a change in control, if Mr. Hatfield does not continue to have similar responsibilities in the surviving or acquiring company or if he is required to relocate his office by more than 50 miles, all of his then-unvested stock options will become fully vested and exercisable.

Severance Benefits

        Pursuant to the letter agreement he entered into with us in February 2004, as amended from time to time, if we terminate the employment of Mr. Hatfield without cause, then he will be eligible to receive, contingent on his timely executing and not revoking a general release of all claims he may have against us and on his returning all of our property in his possession, continued payments of his then-current base salary for a period of 12 months, plus a payment equal to the bonus he earned in the year preceding his termination.

        Pursuant to the letter agreement he entered into with us in January 2008, as amended from time to time, if we terminate the employment of Dr. Gregg for any reason other than cause or permanent disability, then he will be eligible to receive, contingent on his timely executing and not revoking a general release of all claims he may have against us and on his returning all of our property in his possession, continued payments of his then-current base salary for a period of six months.

        "Cause" means Dr. Gregg's:

    unauthorized use or disclosure of our confidential information or trade secrets, which use or disclosure causes material harm to us;
    material breach of any agreement with us;
    material failure to comply with our written policies or rules;

130